Implantable Glucose Sensor Market Growth Expected to Reach $16.04 Billion by 2030 with 14.5% CAGR
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Is The Market Size Of The Implantable Glucose Sensor Market Expected To Change Between 2026 And 2030?
The implantable glucose sensor market has experienced substantial growth in recent years. This market is anticipated to expand from $8.14 billion in 2025 to $9.34 billion in 2026, reflecting a compound annual growth rate (CAGR) of 14.7%. The observed growth during prior periods is attributable to factors such as the increasing incidence of diabetes, the disadvantages of finger stick testing, the initial uptake of CGM devices, escalating healthcare spending, and enhancements in sensor accuracy.
The implantable glucose sensor market is projected to undergo significant expansion in the coming years, reaching $16.05 billion in 2030 at a compound annual growth rate (CAGR) of 14.5%. This anticipated growth is influenced by several factors, including the increasing demand for long-term monitoring solutions, their integration with insulin delivery systems, a growing global diabetic population, continuous technological miniaturization, and favorable reimbursement policies. Key trends expected during this forecast period involve the development of long-duration implantable monitoring devices, the move towards finger prick-free diabetes management, advancements in biocompatible sensor materials, the provision of continuous real-time glucose tracking, and a rising preference for home-based monitoring.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30300&type=smp
What Drivers Are Expected To Influence The Implantable Glucose Sensor Market During The Forecast Period?
The increasing prevalence of diabetes is anticipated to drive the expansion of the implantable glucose sensor market in the coming years. Diabetes is a chronic medical condition where the body struggles to properly regulate blood sugar or glucose levels. This rise in diabetes cases is largely due to unhealthy lifestyles, such as reduced physical activity and increased consumption of high-calorie foods, which heightens the risk of developing type 2 diabetes. Implantable glucose sensors assist in diabetes management by offering continuous and long-term monitoring of blood glucose levels, making them highly suitable for patients who require precise glucose control. They reduce the need for frequent finger-prick tests by supplying real-time data and alerts, thereby improving overall patient convenience and health outcomes. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the growing prevalence of diabetes is a key factor propelling the growth of the implantable glucose sensor market.
How Is The Implantable Glucose Sensor Market Structured Across Different Segments?
The implantable glucose sensor market covered in this report is segmented –
1) By Product Type: Long-term Implantable Sensors, Short-term Implantable Sensors
2) By Technology: Enzymatic, Non-Enzymatic
3) By Application: Type 1 Diabetes, Type 2 Diabetes
4) By End-User: Hospitals, Clinics, Homecare Settings, Other End-Users
Subsegments:
1) By Long-Term Implantable Sensors: Enzyme-Based, Electrochemical, Fluorescence-Based
2) By Short-Term Implantable Sensors: Minimally Invasive, Biocompatible Hydrogel-Based
Which Trends Are Shaping The Future Of The Implantable Glucose Sensor Market?
Major companies operating in the implantable glucose sensor market are concentrating on developing advanced offerings, such as long-duration implantable sensors, to enhance patient convenience, improve health outcomes, and reduce the frequency of device maintenance. Long-term implantable sensors are innovative medical devices inserted under the skin to continuously measure glucose levels in the interstitial fluid for extended periods, unlike short-term sensors which necessitate frequent replacement. For instance, in September 2024, Senseonics Holdings Inc., a US-based medical technology company, obtained approval from the U.S. Food and Drug Administration (FDA) for its Eversense 365 continuous glucose monitoring system for individuals with Type 1 and Type 2 diabetes aged 18 years and older. This system features a fully implantable sensor that lasts up to 365 days, providing ongoing glucose readings and alerts for high and low glucose levels. It also integrates with a mobile app and cloud-based platform, enabling patients and healthcare providers to track glucose trends and make informed treatment decisions remotely.
Which Major Players Dominate The Implantable Glucose Sensor Market?
Major companies operating in the implantable glucose sensor market are Senseonics Holdings Inc., GlySens Incorporated, Profusa Inc., Abbott Laboratories, Dexcom Inc., Medtronic plc, Biolinq Inc., Nemaura Medical Inc., Integrated Sensing Systems Inc., WaveForm Technologies Inc., BioMems Solutions Inc., Echo Therapeutics Inc., Glucovation Inc., Know Labs Inc., Pacific Diabetes Technologies Inc., Metronom Health Inc., AliveCor Diabetes Inc., Pixelligent Technologies Inc., OrSense Ltd., Medtrum Technologies Inc.
Read the full implantable glucose sensor market report here:
https://www.thebusinessresearchcompany.com/report/global-implantable-glucose-sensor-market-report
Which Region Is Forecast To Lead The Implantable Glucose Sensor Market In Terms Of Market Size?
North America was the largest region in the implantable glucose sensor market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable glucose sensor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Implantable Glucose Sensor Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=30300&type=smp
Browse Through More Reports Similar to the Global Implantable Glucose Sensor Market 2026, By The Business Research Company
Continuous Glucose Monitoring Devices Market Report 2026
Blood Glucose Monitoring Systems Market Report 2026
Continous Blood Glucose Monitoring Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
